DE Piccioni, CM Duma, RV LaRocca, R. Aiken, TH Taylor, JA Carrillo, GI Nistor, HS Keirstead, Robert O. Dillman, DA Bota, Robert O. Dillman
{"title":"Enhanced Progression-Free Survival in a Phase 2 Trial of Personal Dendritic Cell Vaccines in Patients with Newly Diagnosed Glioblastoma","authors":"DE Piccioni, CM Duma, RV LaRocca, R. Aiken, TH Taylor, JA Carrillo, GI Nistor, HS Keirstead, Robert O. Dillman, DA Bota, Robert O. Dillman","doi":"10.29011/2574-710x.010149","DOIUrl":null,"url":null,"abstract":"Standard therapy of aggressive glioblastoma (GBM), which includes maximum safe surgical resection and concurrent radiation/temozolomide (RT/TMZ) followed by maintenance TMZ, is associated with poor progression-free survival (PFS) and overall","PeriodicalId":73876,"journal":{"name":"Journal of oncology research and therapy","volume":"49 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of oncology research and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2574-710x.010149","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Standard therapy of aggressive glioblastoma (GBM), which includes maximum safe surgical resection and concurrent radiation/temozolomide (RT/TMZ) followed by maintenance TMZ, is associated with poor progression-free survival (PFS) and overall
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
